7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

DICE Therapeutics
(NASDAQ:DICE) 

DICE stock logo

DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It designs and develops therapies in immunology for patients with chroni...

Founded: 2013
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
DICE Therapeutics Days Receivable Outstanding ttm (DSO)
202203 202204 202205 202206 202207 202208 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0463.49926.981,390.481,853.972,317.462,780.953,244.44
DICE Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.29-1.96-1.64-1.31-0.98-0.65-0.330
DICE Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.36-2.03-1.69-1.35-1.01-0.68-0.340
DICE Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.813.615.427.229.0310.8312.64
DICE Therapeutics P/S ratio ttm
202203 202204 202205 202206 202207 202208 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0479.39958.771,438.161,917.542,396.932,876.313,355.7
DICE Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -26.58-22.79-18.99-15.19-11.39-7.6-3.80
DICE Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.47-8.23-5.98-3.74-1.50.752.995.24
No extra charts and metrics for this ticker.